Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Richard D. Williams, Tasnim Chagtai, Marisa Alcaide-German, John Apps, Jenny Wegert, Sergey Popov, Gordan Vujanic, Harm van Tinteren, Marry M. van den Heuvel-Eibrink, Marcel Kool, Jan de Kraker, David Gisselsson, Norbert Graf, Manfred Gessler, Kathy Pritchard-Jones
Published Jan 31, 2015 · Vol. 6, No. 9 · pp. 7232-7243
Noemi Perez-Janices, Idoia Blanco-Luquin, Maria Teresa Tuñón, Edurne Barba-Ramos, Berta Ibáñez, Idoya Zazpe-Cenoz, Maria Teresa Martinez-Aguillo, Berta Hernandez, Enrique MartÃnez-Lopez, Agustin F. Fernández, Maria Roasario Mercado, Teresa Cabada, David Escors, Diego Megias, David Guerrero-Setas
Published Jan 24, 2015 · Vol. 6, No. 1 · pp. 368-380
Keywords: Brain tumors, EPB41L3, DNA methylation, prognosis, RASSF2, TSP-1.
Jeff P. Bruce, Angela B.Y. Hui, Wei Shi, Bayardo Perez-Ordonez, Ilan Weinreb, Wei Xu, Benjamin Haibe-Kains, Daryl M. Waggott, Paul C. Boutros, Brian O’Sullivan, John Waldron, Shao Hui Huang, Eric X. Chen, Ralph Gilbert, Fei-Fei Liu
Published Jan 23, 2015 · Vol. 6, No. 6 · pp. 4537-4550